Chester County News and Community Website
BERWYN, PA — Panavance Therapeutics Inc. announced the U.S. Food and Drug Administration (FDA) recently granted Orphan Drug Designation to GP-2250 for the treatment of all forms of pancreatic cancer.
Panavance Therapeutics Announces Orphan Drug Designation for GP-2250 Read More
BERWYN, PA — Panavance Therapeutics Inc. announced the recent publication of positive data from a preclinical study evaluating GP-2250 for the treatment of pancreatic neuroendocrine carcinoma. The manuscript titled, “New …
Panavance Therapeutics Announces Publication of Encouraging Preclinical Data Evaluating GP-2250 Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced the recent publication of preclinical research of zunsemetinib in pancreatic cancer in the peer-reviewed journal Science Translational Medicine, on December 1, …
Aclaris Therapeutics Announces Publication of Preclinical Research of Zunsemetinib Read More
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy …
Galera Announces First Patient Dosed with GC4711 in Phase 2b GRECO-2 Trial Read More MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) recently announced that Science Translational Medicine has published a foundational preclinical article describing the synergy of avasopasem manganese, one of the Company’s selective …
Article Shows Galera’s Selective Dismutase Mimetic Synergizes with Radiotherapy to Ablate Tumors Read MoreWEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI), a clinical stage radiopharmaceutical therapy company focused on therapies for rare diseases, announced the approval of an Investigational New Drug (IND) …
West Chester-based Biotech Company Receives FDA Approval for Investigational New Drug Read MoreWASHINGTON, D.C. — The U.S. Food and Drug Administration recently authorized marketing of the EndoRotor System to resect (cut out) and remove necrotic (dead) tissue for patients with walled-off pancreatic …
FDA Authorizes Marketing of New Device Designed to Remove Dead Pancreatic Tissue Read More